These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35521969)

  • 21. Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice.
    Amruta N; Ismael S; Leist SR; Gressett TE; Srivastava A; Dinnon KH; Engler-Chiurazzi EB; Maness NJ; Qin X; Kolls JK; Baric RS; Bix G
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection.
    Savelieff MG; Feldman EL; Stino AM
    Neurobiol Dis; 2022 Jun; 168():105715. PubMed ID: 35364273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 ORF3a expression in brain disrupts the autophagy-lysosomal pathway, impairs sphingolipid homeostasis, and drives neuropathogenesis.
    Zhu H; Byrnes C; Lee YT; Tuymetova G; Duffy HBD; Bakir JY; Pettit SN; Angina J; Springer DA; Allende ML; Kono M; Proia RL
    FASEB J; 2023 May; 37(5):e22919. PubMed ID: 37071464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.
    Ng JH; Sun A; Je HS; Tan EK
    Neuroscientist; 2023 Feb; 29(1):30-40. PubMed ID: 34036855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
    Alves RPDS; Wang YT; Mikulski Z; McArdle S; Shafee N; Valentine KM; Miller R; Verma SK; Batiz FAS; Maule E; Nguyen MN; Timis J; Mann C; Zandonatti M; Alarcon S; Rowe J; Kronenberg M; Weiskopf D; Sette A; Hastie K; Saphire EO; Festin S; Kim K; Shresta S
    Antiviral Res; 2023 Apr; 212():105580. PubMed ID: 36940916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19.
    Beckman D; Bonillas A; Diniz GB; Ott S; Roh JW; Elizaldi SR; Schmidt BA; Sammak RL; Van Rompay KKA; Iyer SS; Morrison JH
    Cell Rep; 2022 Nov; 41(5):111573. PubMed ID: 36288725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mouse Model of MHV-1 Virus Infection for Study of Acute and Long COVID Infection.
    Masciarella AD; Di Gregorio DM; Ramamoorthy R; Hussain H; Jayakumar AR; Paidas MJ
    Curr Protoc; 2023 Oct; 3(10):e896. PubMed ID: 37867460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
    Klein RS
    Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
    Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
    EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis.
    Zeiss CJ; Compton S; Veenhuis RT
    ILAR J; 2021 Dec; 62(1-2):35-47. PubMed ID: 33836527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series.
    Becker RC
    J Thromb Thrombolysis; 2021 Oct; 52(3):692-707. PubMed ID: 34403043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses.
    Spatola M; Nziza N; Jung W; Deng Y; Yuan D; Dinoto A; Bozzetti S; Chiodega V; Ferrari S; Lauffenburger DA; Mariotto S; Alter G
    Brain; 2023 Oct; 146(10):4292-4305. PubMed ID: 37161609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
    Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
    Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.